BDX P/FCF 14.9 | Overview

Search global stocks & ETFs...Ctrl K

Learn Mode

Becton Dickinson and CoBDX

$165.62

$0.17 (0.103%)

at close

3.63/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Updates

BDX

Stock Profile

Market Cap

Industry

EPS (TTM)

P/E (TTM)

Div & Yield

FCF Payout Ratio

P/S (TTM)

P/B

Revenue Growth (TTM)

EPS CAGR (3Y)

Diluted Shares

Ex-Dividend

Next Earnings

Forward P/E

Payout Ratio

P/FCF (TTM)

FCF Yield

Earnings Yield

Revenue CAGR (3Y)

Recommended Metric

Score Card

Explore Scores Tab

3.63

Good

Becton Dickinson and Co has grown revenue at 2.39% over the past year, which suggests sales are increasing. Also, it has seen its diluted average shares outstanding decrease by -2.47% over the past year, which suggests the company is buying back shares.

Valuation Score

Key Score

3.00

Average

Management

3.00

Average

Growth

3.00

Average

Profitability

5.00

Very Good

Fin. Health

2.00

Bad

Dividends

3.00

Average

Analyst

2.00

Bad

Financials

Explore Financial Tab ›

Revenue

Earnings

Free Cash Flow

Insider Transactions

Explore Insider Tab ›

Buy Transactions

Sell Transactions

Peers

Select stocks to compare

ABTAbbott Laboratories

IDXXIdexx Laboratories Inc

ZBHZimmer Biomet Holdings, Inc

$93.93

-1.08%

EWEdwards Lifesciences Corp

$86.07

-0.98%

GEHCGe Healthcare Technologies Inc

ISRGIntuitive Surgical Inc

$353.33

+0.10%

BSXBoston Scientific Corp

$46.73

+1.59%

Price Targets & Ratings

View Analysis

1-year price targets, ending Jun 28, 2027

Current

$165.62

Baseline

High

$236.95

▲

43.07%

Avg

$187.10

▲

12.97%

Low

$151.50

▼

-8.53%

Analyst Ratings based on 21 Analysts

Strong Buy

24%

Buy

19%

Hold

57%

Sell

00%

Strong Sell

00%

About

Stock News

View All Updates